Use of intracameral phenylephrine to manage iris prolapse.
Allen
David
D
D058668:Adrenergic alpha-1 Receptor Antagonists; D000317:Adrenergic alpha-Antagonists / Q000009:adverse effects*; D006801:Humans; D007431:Intraoperative Complications; D007499:Iris Diseases / Q000139:chemically induced / Q000188:drug therapy* / Q000601:surgery; D009184:Mydriatics / Q000627:therapeutic use*; D013508:Ophthalmologic Surgical Procedures / Q000295:instrumentation / Q000379:methods; D018918:Phacoemulsification; D010656:Phenylephrine / Q000627:therapeutic use*; D011391:Prolapse; D013449:Sulfonamides / Q000009:adverse effects*; D013577:Syndrome; D000077409:Tamsulosin; D014792:Visual Acuity
D058668:Adrenergic alpha-1 Receptor Antagonists; D000317:Adrenergic alpha-Antagonists; D009184:Mydriatics; D013449:Sulfonamides; D010656:Phenylephrine; D000077409:Tamsulosin